RMaIDSM
What it found
No result yet.
What was tested
Treatment tested
- Interferon beta-1a
Interferon alpha/beta receptor agonist
Compared with
- Glatiramer acetate
Unknown
What it measured
Main measures
. evaluation of blood-brain barrier permeability
Who could take part
Relapsing MS
Inclusion: - relapsing-remitting Multiple Sclerosis patients elegible to treatment with Interferon beta 1-a (Avonex)i.m. or Glatiramer-acetate (copaxone) s.c Exclusion: . use of steroids and/or symptomatic drugs for fatigue within 30 days, other immunomodulatories within 3 months, immunosuppressant within 6 months
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
to evaluate modifications of MRI parameters related to inflammatory mechanisms; to evaluate modifications of MRI parameters related to neurodegenrative mechanisms
Loading reviews and guidelines…
Related trials
- TWINS
Phase 3 · Not yet recruiting
Still running
- Pregnancy Exposure Registry for Vumerity (Diroximel Fumar…
Recruiting
Still running
- Full Responders
Phase 4 · Stopped early
Stopped early
- A Study to Learn More About The Safety of Diroximel Fumar…
Running, not recruiting
Still running
- Study to Investigate Pregnancy Outcomes in Female Partici…
Completed
Result in a paper, not read yet
- 105MS306
Phase 3 · Running, not recruiting
Still running
History
Started
Nov 2008
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error